LY 294002 inhibits adenosine receptor activation by a mechanism independent of effects on PI-3 kinase or casein kinase II

Abstract

Adenosine reduces both evoked and spontaneous calcium-dependent acetylcholine (ACh) release through a mechanism downstream of calcium entry at amphibian motor nerve endings (Silinsky EM. J Physiol 1984; 346: 243Y56). LY 294002 (2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one), an inhibitor of both phosphoinositide-3 kinase (PI-3 kinase) and casein kinase II, has been reported to increase spontaneous ACh release reflected in miniature endplate potential (MEPP) frequencies independently of intraterminal calcium at the frog neuromuscular junction (Rizzoli SO, Betz WJ. J Neurosci 2002; 22: 10680Y9). It has been suggested that the increase in MEPP frequency caused by LY 294002, is mediated through an action on synaptotagmins, vesicle associated calcium sensors believed to trigger synaptic vesicle exocytosis. We thus examined the effects of adenosine on MEPP frequencies and evoked ACh release reflected as endplate potentials (EPPs) in order to determine if the presumed calcium-independent ACh release is affected by adenosine. We also wanted to determine if PI-3 kinase or casein kinase II is involved in mediating or modulating the inhibitory effects of adenosine. To these ends, we examined the effects of adenosine in the presence of LY 294002, wortmannin (a highly selective the PI-3 kinase inhibitor), or DRB (5,6-dichlorobenzimidazole riboside, an inhibitor of casein kinase II). LY 294002 reduced the sensitivity of both MEPP frequencies and the nerve-evoked calcium dependent EPPs to adenosine. The occlusive effects of LY 294002 on the actions of adenosine on MEPPs and EPPs were overcome by increasing adenosine concentration. Neither wortmannin nor DRB had any effect on the sensitivity of the EPPs to adenosine indicating that neither PI-3 kinase nor casein kinase II inhibition mediates the reduction in motor-nerve terminal sensitivity to adenosine produced by LY 294002. The results indicate a competitive relationship between LY 294002 and adenosine at A 1 receptors at the frog neuromuscular junction. This effect is independent of the previously described effects of LY 294002 on the exocytotic process, and is also independent of PI-3 kinase or casein kinase II.Abbreviations: ACh -acetylcholine; DRB -5,6-dichlorobenzimidazole riboside; EPPs -end-plate potentials; LY 294002 -2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; MEPPs -miniature end-plate potentials; PI-3 kinase -phosphoinositide-3 kinase

Oct4 Interaction with Hmgb2 Regulates Akt Signaling and Pluripotency

“…Since LY may also target other signaling pathways [31], we directly assessed the impact of Akt upon Oct4 by treatment with Akti1/2, a potent and specific Akt inhibitor [32]. Treatment of mESCs with increasing amounts of Akti1/2 resulted in a dose‐dependent reduction in pAkt Thr308 and Ser473 (Fig.…”

Cooperative oncogenic effect and cell signaling crosstalk of co-occurring HER2 and mutant PIK3CA in mammary epithelial cells

“…LY294002 [pan PI3K inhibitor ( 24 , 25 )], and CP-724714 [selective HER2 inhibitor ( 26 , 27 )] were diluted to the concentrations of 3 and 10 μ M and 0.1 and 1 μ M in SFIHE medium, respectively, according to previous data. SFIHE medium with either concentration of the PI3K inhibitor, the HER2 inhibitor, or both inhibitors at both concentrations were added to only the MCF10A cell line expressing both the mutant PIK3CA -H1047R and the HER2 gene in a 96-well plate for cell growth, and in 6-well plates for colony formation with 2.5×10 4 cells/well.…”

Effect of purines on calcium-independent acetylcholine release at the mouse neuromuscular junction

“…Since in others systems, it was shown that ADP stimulates phosphoinositide-3 kinase (PI3K) through P2Y 12 receptors, and this pathways have been implicated in integrin activation (see discussion, Kauffenstein et al, 2001;Dorsam and Kunapuli, 2004;Jackson et al, 2004;Sun et al, 2005), we studied the effect of LY-294002, a reversible inhibitor of PI3K and casein kinase II, upon the modulation of the hypertonic response induced by CCPA and 2-Me-SADP. At frog neuromuscular junctions, it was found that LY-294002 increases MEPP frequency through a mechanism independent of internal calcium concentration (Rizzoli and Betz, 2002;Searl and Silinsky, 2005), this action being transient at high concentrations of the drug (Rizzoli and Betz 2002). Thus, we first tested the time-dependent action of LY-294002 on MEPP frequency.…”